XM does not provide services to residents of the United States of America.

BOJ may get a lot less bang for their bucks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-COMMENT-BOJ may get a lot less bang for their bucks</title></head><body>

Oct 24 (Reuters) -Should Japan's central bank intervene to support the yen it may have to sell far more dollars to achieve the same results as in prior moves.

The law of diminishing returns has clearly applied to the process of intervention to support the yen, with the record size of dollar sales in 2022 far exceeded by those this year which had much less effect.

Where intervention in 2022 led to a 23 yen rise, the yen proved much more resilient when it rose roughly 8 yen after 62 billion dollars were sold in July.

The currency only rose further after the Bank of Japan raised interest rates and laid out its plans to tighten more at the end of July, which caused a risk-averse shock that drove stocks much lower and led to a purge of yen-funded carry trades.

Stocks have since rebounded and the yen, which recently dropped below 153 versus the dollar, has given back the gains that followed July's BOJ meeting.

When the BOJ sold dollars in the past, traders were betting heavily on the yen falling. Until recently they were gambling that the yen would rise. Without speculation to counter, any move to support the yen will be less effective.

At 2.8 trillion yen, the intervention in September 2022 was far eclipsed by the almost 10 trillion spent in July this year, and with no yen shorts to squeeze, an even bigger spend may be needed to boost the Japanese currency significantly.

Japan's seemingly ample reserves of almost $1.1 trillion could be rapidly diminished, and should that happen without sustaining a yen rise - likely given Japan's very easy monetary policy, it could spur on a run on the yen.


South African Rand could be new darling of carry trades nL1N3M00CT

For more click on FXBUZ


(Jeremy Boulton is a Reuters market analyst. The views expressed are his own)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.